A precision diagnostic device predicting therapy resistance– a new generation multidrug transporter kit
A precision diagnostic device predicting therapy resistance– a new generation multidrug transporter kit
We’re developing an innovative diagnostic platform built on over 30 years of research into multidrug transporters. Using cutting-edge, proprietary measurement technology, this tool accurately and independently assesses the functional activity of the three key transporter proteins—ABCB1 (P-gp), ABCC1 (MRP1), and ABCG2 (BCRP)—with exceptional speed and sensitivity. Designed to support real-world clinical decision-making, it sets a new standard for precision in patient care.
The device under development will meet the following requirements
Our experienced team offers specialized expertise in molecular biology, cell culture, and immunology, and is ready to support both pre-clinical and clinical development phases with in-depth knowledge and insight.
Our fully equipped R&D laboratory conducts research using selected cell lines and primary cells, with a strong emphasis on high-quality flow cytometry analysis.
"*" indicates required fields